Skip to content

Pharma4Future

Active Risk: not assessed
Private limited companyfounded 2021active for 4 yearsHeiveld 29, 1745 Opwijk, BelgiumKBO/BCE: BE 0776.403.737
Summary

Pharma4Future is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €563,772 and a net result of €246,977. Equity is growing by about 85% per year across the filed financial years. Its solvency ranks better than 14% of 6,640 sector peers (NACE 64, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.

History

On 22 October 2021, Pharma4Future was incorporated as a private limited company.1 Total assets went from €3.8m in 2022 to €5.0m in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2022 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
02-07
NBB filing Annual accounts filed
financial year 2025 · abbreviated format
02-04
Gazette deed Permanent representative: Thomas Elpers
Resignation: Elpers Farma BV (director) · Director discharge7 facts ▸
  • General meeting, 12-03-2026
  • Permanent representative, Thomas Elpers
  • Other provision, “vrijwillig ontslag bestuurder” (deed in Dutch)
  • Director resignation, Elpers Farma BV (director)
  • Other provision, “elk individueel, geen kwijting” (deed in Dutch) (3 times)
  • Other provision, “kwijting, tussentijdse kwijting ontslagnemende bestuurder” (deed in Dutch)
  • Director discharge, Elpers Farma BV (director)
2025
31-12
Financial Highest result from 2022 to 2025net €246,977 ▲90.4%
Operating result €419,561, net result €246,977, both a record.
31-12
Financial Equity above €500,000equity €563,772 ▲78%
A profit in every financial year since 2022 builds equity to €563,772.
17-06
NBB filing Annual accounts filed
financial year 2024 · abbreviated format
2024
31-12
Financial Equity above €200,000equity €316,795 ▲69.3%
A profit in every financial year since 2022 builds equity to €316,795.
28-06
NBB filing Annual accounts filed
financial year 2023 · abbreviated format
2023
31-12
Financial Equity above €150,000equity €187,083 ▲133%
A profit in every financial year since 2022 builds equity to €187,083.
10-08
NBB filing Annual accounts filed
financial year 2022 · abbreviated format · 10 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts

Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.